Helen H. Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Helen H. Lu has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Z. Mosher
Department of Biomedical Engineering, Columbia University Fu Foundation School of Engineering and Applied Science, 351 Engineering Terrace, 1210 Amsterdam Avenue, New York, NY 10027, USA, New York, New York, 10027, UNITED STATES
4 shared publications Danielle R. Bogdanowicz
Biomaterials and Interface Tissue Engineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, New York
4 shared publicationsDovina Qu
Biomaterials and Interface Tissue Engineering Laboratory, Department of Biomedical Engineering, Columbia University, 351 Engineering Terrace Building, MC 8904, 1210 Amsterdam Avenue, New York, NY 10027, United States
4 shared publicationsMargaret K. Boushell
Biomaterials and Interface Tissue Engineering Laboratory, Department of Biomedical Engineering Columbia University New York New York
4 shared publications- Cevat Erisken
Department of Chemical and Materials Engineering, School of Engineering and Digital Sciences, Nazarbayev University, 010000 Astana, Kazakhstan
3 shared publications Jeffrey P. Spalazzi
Biomaterials and Interface Tissue Engineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, NY 10027, United States
3 shared publications
Latest Publications
- Open Access
Deep Learning Approach to Measure Alveolar Bone Loss After COVID-19
Severity of periodontal disease may be determined by measurement of alveolar crestal height (ACH) on dental bitewing radiographs; however, the prevailing method of assessment is through visualization which is time consuming and not a direct measure. The primary objective of this manuscript is to create and validate a deep learning technique for precise evaluation of alveolar bone loss in bitewing radiographs. Additionally, surveys were conducted with dental professionals to determine accuracy of visualized measures of ACH for severe periodontal disease versus the deep learning program and to determine the acceptability of utility of the program among diverse dental professionals. Lastly, the deep learning program was utilized in research to evaluate the role of COVID on periodontal disease through longitudinal measures of bitewing radiograph ACH from patients during the: "pre-pandemic" (Feb 2017 - Feb 2020) and "post-pandemic" (Feb 2020 - Feb 2023) periods. The pre-pandemic group had a mean percentage loss of ACH of -1.74 + 16.5%, representing a gain in alveolar bone. In contrast, the post-pandemic group had a gain in ACH of 2.46 + 14.6%, representing a loss in alveolar bone. There remained a trend for greater annualized percent change in ACH in the post-pandemic vs pre-pandemic group (1.33 + 11.9% vs -0.94 + 12.5%, p=0.07), after accounting for differences in duration between xrays. Overall, this study demonstrates the successful training and validation of a deep learning program for ACH measurement as well as its utility and acceptability among dental professionals for clinical and research.
Open AccessDeep Learning Approach to Measure Alveolar Bone Loss After COVID-19
Severity of periodontal disease may be determined by measurement of alveolar crestal height (ACH) on dental bitewing radiographs; however, the prevailing method of assessment is through visualization which is time consuming and not a direct measure. The primary objective of this manuscript is to create and validate a deep learning technique for precise evaluation of alveolar bone loss in bitewing radiographs. Additionally, surveys were conducted with dental professionals to determine accuracy of visualized measures of ACH for severe periodontal disease versus the deep learning program and to determine the acceptability of utility of the program among diverse dental professionals. Lastly, the deep learning program was utilized in research to evaluate the role of COVID on periodontal disease through longitudinal measures of bitewing radiograph ACH from patients during the: "pre-pandemic" (Feb 2017 - Feb 2020) and "post-pandemic" (Feb 2020 - Feb 2023) periods. The pre-pandemic group had a mean percentage loss of ACH of -1.74 + 16.5%, representing a gain in alveolar bone. In contrast, the post-pandemic group had a gain in ACH of 2.46 + 14.6%, representing a loss in alveolar bone. There remained a trend for greater annualized percent change in ACH in the post-pandemic vs pre-pandemic group (1.33 + 11.9% vs -0.94 + 12.5%, p=0.07), after accounting for differences in duration between xrays. Overall, this study demonstrates the successful training and validation of a deep learning program for ACH measurement as well as its utility and acceptability among dental professionals for clinical and research.
- Open Access
- 14 October 2022
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 925838
Engineering collagenous analogs of connective tissue extracellular matrix
Connective tissue extracellular matrix (ECM) consists of an interwoven network of contiguous collagen fibers that regulate cell activity, direct biological function, and guide tissue homeostasis throughout life. Recently, ECM analogs have emerged as a unique ex vivo culture platform for studying healthy and diseased tissues and in the latter, enabling the screening for and development of therapeutic regimen. Since these tissue models can mitigate the concern that observations from animal models do not always translate clinically, the design and production of a collagenous ECM analogue with relevant chemistry and nano- to micro-scale architecture remains a frontier challenge in the field. Therefore, the objectives of this study are two-fold— first, to apply green electrospinning approaches to the fabrication of an ECM analog with nanoscale mimicry and second, to systematically optimize collagen crosslinking in order to produce a stable, collagen-like substrate with continuous fibrous architecture that supports human cell culture and phenotypic expression. Specifically, the “green” electrospinning solvent acetic acid was evaluated for biofabrication of gelatin-based meshes, followed by the optimization of glutaraldehyde (GTA) crosslinking under controlled ambient conditions. These efforts led to the production of a collagen-like mesh with nano- and micro-scale cues, fibrous continuity with little batch-to-batch variability, and proven stability in both dry and wet conditions. Moreover, the as-fabricated mesh architecture and native chemistry were preserved with augmented mechanical properties. These meshes supported the in vitro expansion of stem cells and the production of a mineralized matrix by human osteoblast-like cells. Collectively these findings demonstrate the potential of green fabrication in the production of a collagen-like ECM analog with physiological relevance. Future studies will explore the potential of this high-fidelity platform for elucidating cell-matrix interactions and their relevance in connective tissue healing.
- 14 October 2022
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 925838
Open AccessEngineering collagenous analogs of connective tissue extracellular matrix
Connective tissue extracellular matrix (ECM) consists of an interwoven network of contiguous collagen fibers that regulate cell activity, direct biological function, and guide tissue homeostasis throughout life. Recently, ECM analogs have emerged as a unique ex vivo culture platform for studying healthy and diseased tissues and in the latter, enabling the screening for and development of therapeutic regimen. Since these tissue models can mitigate the concern that observations from animal models do not always translate clinically, the design and production of a collagenous ECM analogue with relevant chemistry and nano- to micro-scale architecture remains a frontier challenge in the field. Therefore, the objectives of this study are two-fold— first, to apply green electrospinning approaches to the fabrication of an ECM analog with nanoscale mimicry and second, to systematically optimize collagen crosslinking in order to produce a stable, collagen-like substrate with continuous fibrous architecture that supports human cell culture and phenotypic expression. Specifically, the “green” electrospinning solvent acetic acid was evaluated for biofabrication of gelatin-based meshes, followed by the optimization of glutaraldehyde (GTA) crosslinking under controlled ambient conditions. These efforts led to the production of a collagen-like mesh with nano- and micro-scale cues, fibrous continuity with little batch-to-batch variability, and proven stability in both dry and wet conditions. Moreover, the as-fabricated mesh architecture and native chemistry were preserved with augmented mechanical properties. These meshes supported the in vitro expansion of stem cells and the production of a mineralized matrix by human osteoblast-like cells. Collectively these findings demonstrate the potential of green fabrication in the production of a collagen-like ECM analog with physiological relevance. Future studies will explore the potential of this high-fidelity platform for elucidating cell-matrix interactions and their relevance in connective tissue healing.
- Open Access
- 27 May 2022
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Advances
- Vol. 1 (3) , 276-284
Microbial nanocellulose biotextiles for a circular materials economy
Harnessing microbial biofabrication coupled to a protocol inspired by indigenous textile processes, we engineer high-performance biotextiles with a sustainable circular life cycle, including the plant and mineral dyed bioleather sneakers shown.
- 27 May 2022
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Advances
- Vol. 1 (3) , 276-284
Open AccessMicrobial nanocellulose biotextiles for a circular materials economy
Harnessing microbial biofabrication coupled to a protocol inspired by indigenous textile processes, we engineer high-performance biotextiles with a sustainable circular life cycle, including the plant and mineral dyed bioleather sneakers shown.
- Open Access
Microbial Nanocellulose Biotextiles for a Circular Materials Economy
Harnessing microbial biofabrication and inspired by indigenous practices, we engineer high-performance microbial nanocellulose (MC) biotextiles with a sustainable circular life cycle. Specifically, our plant-based lecithin phosphocholine treatment modulates cellulose cross-linking through phosphate and methylene groups, to yield a biodegradable material with superior mechanical and flame-retardant properties. Coloration is achieved using natural dyes and waste-to-resource strategies. Life cycle impact assessment reveals MC biotextiles mitigate the carcinogenics of leather by a factor of 103 and the carbon footprint of synthetic leather and cotton by ~97%, for widespread application in fashion, interiors, and construction. The translational potential of this approach is tremendous, as using microbes and green chemistry to engineer regenerative, high-performance products will disrupt linear production models and mitigate its environmental threats in a circular economy.
Open AccessMicrobial Nanocellulose Biotextiles for a Circular Materials Economy
Harnessing microbial biofabrication and inspired by indigenous practices, we engineer high-performance microbial nanocellulose (MC) biotextiles with a sustainable circular life cycle. Specifically, our plant-based lecithin phosphocholine treatment modulates cellulose cross-linking through phosphate and methylene groups, to yield a biodegradable material with superior mechanical and flame-retardant properties. Coloration is achieved using natural dyes and waste-to-resource strategies. Life cycle impact assessment reveals MC biotextiles mitigate the carcinogenics of leather by a factor of 103 and the carbon footprint of synthetic leather and cotton by ~97%, for widespread application in fashion, interiors, and construction. The translational potential of this approach is tremendous, as using microbes and green chemistry to engineer regenerative, high-performance products will disrupt linear production models and mitigate its environmental threats in a circular economy.
- 28 June 2021
- Published by IOP Publishing in Biofabrication
- Vol. 13 (3) , 035049
Green electrospinning for biomaterials and biofabrication
Green manufacturing has emerged across industries, propelled by a growing awareness of the negative environmental and health impacts associated with traditional practices. In the biomaterials industry, electrospinning is a ubiquitous fabrication method for producing nano- to micro-scale fibrous meshes that resemble native tissues, but this process traditionally utilizes solvents that are environmentally hazardous and pose a significant barrier to industrial scale-up and clinical translation. Applying sustainability principles to biomaterial production, we have developed a ‘green electrospinning’ process by systematically testing biologically benign solvents (U.S. Food and Drug Administration Q3C Class 3), and have identified acetic acid as a green solvent that exhibits low ecological impact (global warming potential (GWP) = 1.40 CO 2 eq. kg/L) and supports a stable electrospinning jet under routine fabrication conditions. By tuning electrospinning parameters, such as needle-plate distance and flow rate, we updated the fabrication of widely utilized biomedical polymers (e.g. poly-α-hydroxyesters, collagen), polymer blends, polymer-ceramic composites, and growth factor delivery systems. Resulting ‘green’ fibers and composites are comparable to traditional meshes in terms of composition, chemistry, architecture, mechanical properties, and biocompatibility. Interestingly, material properties of green synthetic fibers are more biomimetic than those of traditionally electrospun fibers, doubling in ductility (91.86 ± 35.65 vs. 45 ± 15.07%, n = 10, p < 0.05) without compromising yield strength (1.32 ± 0.26 vs. 1.38 ± 0.32 MPa) or ultimate tensile strength (2.49 ± 0.55 vs. 2.36 ± 0.45 MPa). Most importantly, green electrospinning proves advantageous for biofabrication, rendering a greater protection of growth factors during fiber formation (72.30 ± 1.94 vs. 62.87 ± 2.49% alpha helical content, n = 3, p < 0.05) and recapitulating native ECM mechanics in the fabrication of biopolymer-based meshes (16.57 ± 3.92% ductility, 33.38 ± 30.26 MPa elastic modulus, 1.30 ± 0.19 MPa yield strength, and 2.13 ± 0.36 MPa ultimate tensile strength, n = 10). The eco-conscious approach demonstrated here represents a paradigm shift in biofabrication, and will accelerate the translation of scalable biomaterials and biomimetic scaffolds for tissue engineering and regenerative medicine.
- 28 June 2021
- Published by IOP Publishing in Biofabrication
- Vol. 13 (3) , 035049
Green electrospinning for biomaterials and biofabrication
Green manufacturing has emerged across industries, propelled by a growing awareness of the negative environmental and health impacts associated with traditional practices. In the biomaterials industry, electrospinning is a ubiquitous fabrication method for producing nano- to micro-scale fibrous meshes that resemble native tissues, but this process traditionally utilizes solvents that are environmentally hazardous and pose a significant barrier to industrial scale-up and clinical translation. Applying sustainability principles to biomaterial production, we have developed a ‘green electrospinning’ process by systematically testing biologically benign solvents (U.S. Food and Drug Administration Q3C Class 3), and have identified acetic acid as a green solvent that exhibits low ecological impact (global warming potential (GWP) = 1.40 CO 2 eq. kg/L) and supports a stable electrospinning jet under routine fabrication conditions. By tuning electrospinning parameters, such as needle-plate distance and flow rate, we updated the fabrication of widely utilized biomedical polymers (e.g. poly-α-hydroxyesters, collagen), polymer blends, polymer-ceramic composites, and growth factor delivery systems. Resulting ‘green’ fibers and composites are comparable to traditional meshes in terms of composition, chemistry, architecture, mechanical properties, and biocompatibility. Interestingly, material properties of green synthetic fibers are more biomimetic than those of traditionally electrospun fibers, doubling in ductility (91.86 ± 35.65 vs. 45 ± 15.07%, n = 10, p < 0.05) without compromising yield strength (1.32 ± 0.26 vs. 1.38 ± 0.32 MPa) or ultimate tensile strength (2.49 ± 0.55 vs. 2.36 ± 0.45 MPa). Most importantly, green electrospinning proves advantageous for biofabrication, rendering a greater protection of growth factors during fiber formation (72.30 ± 1.94 vs. 62.87 ± 2.49% alpha helical content, n = 3, p < 0.05) and recapitulating native ECM mechanics in the fabrication of biopolymer-based meshes (16.57 ± 3.92% ductility, 33.38 ± 30.26 MPa elastic modulus, 1.30 ± 0.19 MPa yield strength, and 2.13 ± 0.36 MPa ultimate tensile strength, n = 10). The eco-conscious approach demonstrated here represents a paradigm shift in biofabrication, and will accelerate the translation of scalable biomaterials and biomimetic scaffolds for tissue engineering and regenerative medicine.
- 1 July 2019
- Published by Elsevier in Acta Biomaterialia
- Vol. 93, 111-122
Nanofiber-based transforming growth factor-β3 release induces fibrochondrogenic differentiation of stem cells
- 1 July 2019
- Published by Elsevier in Acta Biomaterialia
- Vol. 93, 111-122
Nanofiber-based transforming growth factor-β3 release induces fibrochondrogenic differentiation of stem cells
- 15 April 2019
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1442 (1) , 138-152
Polymeric mesh and insulin‐like growth factor 1 delivery enhance cell homing and graft−cartilage integration
Cartilage injury, such as full‐thickness lesions, predisposes patients to the premature development of osteoarthritis, a degenerative joint disease. While surgical management of cartilage lesions has improved, long‐term clinical efficacy has stagnated, owing to the lack of hyaline cartilage regeneration and inadequate graft−host integration. This study tests the hypothesis that integration of cartilage grafts with native cartilage can be improved by enhancing the migration of chondrocytes across the graft−host interface via the release of chemotactic factor from a degradable polymeric mesh. To this end, a polylactide‐co‐glycolide/poly‐ε‐caprolactone mesh was designed to localize the delivery of insulin‐like growth factor 1 (IGF‐1), a well‐established chondrocyte attractant. The release of IGF‐1 (100 ng/mg) enhanced cell migration from cartilage explants, and the mesh served as critical structural support for cell adhesion, growth, and production of a cartilaginous matrixin vitro, which resulted in increased integration strength compared with mesh‐free repair. Further, this neocartilage matrix was structurally contiguous with native and grafted cartilage when tested in an osteochondral explant modelin vivo. These results demonstrate that this combined approach of a cell homing factor and supportive matrix will promote cell‐mediated integrative cartilage repair and improve clinical outcomes of cartilage grafts in the treatment of osteoarthritis.
- 15 April 2019
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1442 (1) , 138-152
Polymeric mesh and insulin‐like growth factor 1 delivery enhance cell homing and graft−cartilage integration
Cartilage injury, such as full‐thickness lesions, predisposes patients to the premature development of osteoarthritis, a degenerative joint disease. While surgical management of cartilage lesions has improved, long‐term clinical efficacy has stagnated, owing to the lack of hyaline cartilage regeneration and inadequate graft−host integration. This study tests the hypothesis that integration of cartilage grafts with native cartilage can be improved by enhancing the migration of chondrocytes across the graft−host interface via the release of chemotactic factor from a degradable polymeric mesh. To this end, a polylactide‐co‐glycolide/poly‐ε‐caprolactone mesh was designed to localize the delivery of insulin‐like growth factor 1 (IGF‐1), a well‐established chondrocyte attractant. The release of IGF‐1 (100 ng/mg) enhanced cell migration from cartilage explants, and the mesh served as critical structural support for cell adhesion, growth, and production of a cartilaginous matrixin vitro, which resulted in increased integration strength compared with mesh‐free repair. Further, this neocartilage matrix was structurally contiguous with native and grafted cartilage when tested in an osteochondral explant modelin vivo. These results demonstrate that this combined approach of a cell homing factor and supportive matrix will promote cell‐mediated integrative cartilage repair and improve clinical outcomes of cartilage grafts in the treatment of osteoarthritis.
- 20 December 2017
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1410 (1) , 3-25
Designing the stem cell microenvironment for guided connective tissue regeneration
Adult mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine because of their ability to self‐renew and their capacity for multilineage differentiation and tissue regeneration. For connective tissues, such as ligaments or tendons, MSCs are vital to the modulation of the inflammatory response following acute injury while also interacting with resident fibroblasts to promote cell proliferation and matrix synthesis. To date, MSC injection for connective tissue repair has yielded mixed results in vivo, likely due to a lack of appropriate environmental cues to effectively control MSC response and promote tissue healing instead of scar formation. In healthy tissues, stem cells reside within a complex microenvironment comprising cellular, structural, and signaling cues that collectively maintain stemness and modulate tissue homeostasis. Changes to the microenvironment following injury regulate stem cell differentiation, trophic signaling, and tissue healing. Here, we focus on models of the stem cell microenvironment that are used to elucidate the mechanisms of stem cell regulation and inspire functional approaches to tissue regeneration. Recent studies in this frontier area are highlighted, focusing on how microenvironmental cues modulate MSC response following connective tissue injury and, more importantly, how this unique cell environment can be programmed for stem cell–guided tissue regeneration.
- 20 December 2017
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1410 (1) , 3-25
Designing the stem cell microenvironment for guided connective tissue regeneration
Adult mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine because of their ability to self‐renew and their capacity for multilineage differentiation and tissue regeneration. For connective tissues, such as ligaments or tendons, MSCs are vital to the modulation of the inflammatory response following acute injury while also interacting with resident fibroblasts to promote cell proliferation and matrix synthesis. To date, MSC injection for connective tissue repair has yielded mixed results in vivo, likely due to a lack of appropriate environmental cues to effectively control MSC response and promote tissue healing instead of scar formation. In healthy tissues, stem cells reside within a complex microenvironment comprising cellular, structural, and signaling cues that collectively maintain stemness and modulate tissue homeostasis. Changes to the microenvironment following injury regulate stem cell differentiation, trophic signaling, and tissue healing. Here, we focus on models of the stem cell microenvironment that are used to elucidate the mechanisms of stem cell regulation and inspire functional approaches to tissue regeneration. Recent studies in this frontier area are highlighted, focusing on how microenvironmental cues modulate MSC response following connective tissue injury and, more importantly, how this unique cell environment can be programmed for stem cell–guided tissue regeneration.
- Open Access
- 17 November 2017
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 36 (4) , 1069-1077
Integrating soft and hard tissues via interface tissue engineering
The enthesis, or interface between bone and soft tissues such as ligament and tendon, is prone to injury and often does not heal, even post surgical intervention. Interface tissue engineering represents an integrative strategy for regenerating the native enthesis by functionally connecting soft and hard tissues and thereby improving clinical outcome. This review focuses on integrative and cell‐instructive scaffold designs that target the healing of the two most commonly injured soft tissue‐bone junctions: tendon‐bone interface (e.g., rotator cuff) and ligament‐bone interface (e.g., anterior cruciate ligament). The inherent connectivity between soft and hard tissues is instrumental for musculoskeletal motion and is therefore a key design criterion for soft tissue regeneration. To this end, scaffold design for soft tissue regeneration have progressed from single tissue systems to the emerging focus on pre‐integrated and functional composite tissue units. Specifically, a multifaceted, bioinspired approach has been pursued wherein scaffolds are tailored to stimulate relevant cell responses using spatially patterned structural and chemical cues, growth factors, and/or mechanical stimulation. Moreover, current efforts to elucidate the essential scaffold design criteria via strategic biomimicry are emphasized as these will reduce complexity in composite tissue regeneration and ease the related burden for clinical translation. These innovative studies underscore the clinical relevance of engineering connective tissue integration and have broader impact in the formation of complex tissues and total joint regeneration. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1069–1077, 2018.
- 17 November 2017
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 36 (4) , 1069-1077
Open AccessIntegrating soft and hard tissues via interface tissue engineering
The enthesis, or interface between bone and soft tissues such as ligament and tendon, is prone to injury and often does not heal, even post surgical intervention. Interface tissue engineering represents an integrative strategy for regenerating the native enthesis by functionally connecting soft and hard tissues and thereby improving clinical outcome. This review focuses on integrative and cell‐instructive scaffold designs that target the healing of the two most commonly injured soft tissue‐bone junctions: tendon‐bone interface (e.g., rotator cuff) and ligament‐bone interface (e.g., anterior cruciate ligament). The inherent connectivity between soft and hard tissues is instrumental for musculoskeletal motion and is therefore a key design criterion for soft tissue regeneration. To this end, scaffold design for soft tissue regeneration have progressed from single tissue systems to the emerging focus on pre‐integrated and functional composite tissue units. Specifically, a multifaceted, bioinspired approach has been pursued wherein scaffolds are tailored to stimulate relevant cell responses using spatially patterned structural and chemical cues, growth factors, and/or mechanical stimulation. Moreover, current efforts to elucidate the essential scaffold design criteria via strategic biomimicry are emphasized as these will reduce complexity in composite tissue regeneration and ease the related burden for clinical translation. These innovative studies underscore the clinical relevance of engineering connective tissue integration and have broader impact in the formation of complex tissues and total joint regeneration. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1069–1077, 2018.
- 25 May 2017
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 105 (10) , 2694-2702
Effect of ceramic calcium–phosphorus ratio on chondrocyte‐mediated biosynthesis and mineralization
The osteochondral interface functions as a structural barrier between cartilage and bone, maintaining tissue integrity postinjury and during homeostasis. Regeneration of this calcified cartilage region is thus essential for integrative cartilage healing, and hydrogel‐ceramic composite scaffolds have been explored for calcified cartilage formation. The objective of this study is to test the hypothesis that Ca/P ratio of the ceramic phase of the composite scaffold regulates chondrocyte biosynthesis and mineralization potential. Specifically, the response of deep zone chondrocytes to two bioactive ceramics with different calcium–phosphorus ratios (1.35 ± 0.01 and 1.41 ± 0.02) was evaluated in agarose hydrogel scaffolds over two weeksin vitro. It was observed that the ceramic with higher calcium–phosphorus ratio enhanced chondrocyte proliferation, glycosaminoglycan production, and induced an early onset of alkaline phosphorus activity, while the ceramic with lower calcium–phosphorus ratio performed similarly to the ceramic‐free control. These results underscore the importance of ceramic bioactivity in directing chondrocyte response, and demonstrate that Ca/P ratio is a key parameter to be considered in osteochondral scaffold design. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2694–2702, 2017.
- 25 May 2017
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 105 (10) , 2694-2702
Effect of ceramic calcium–phosphorus ratio on chondrocyte‐mediated biosynthesis and mineralization
The osteochondral interface functions as a structural barrier between cartilage and bone, maintaining tissue integrity postinjury and during homeostasis. Regeneration of this calcified cartilage region is thus essential for integrative cartilage healing, and hydrogel‐ceramic composite scaffolds have been explored for calcified cartilage formation. The objective of this study is to test the hypothesis that Ca/P ratio of the ceramic phase of the composite scaffold regulates chondrocyte biosynthesis and mineralization potential. Specifically, the response of deep zone chondrocytes to two bioactive ceramics with different calcium–phosphorus ratios (1.35 ± 0.01 and 1.41 ± 0.02) was evaluated in agarose hydrogel scaffolds over two weeksin vitro. It was observed that the ceramic with higher calcium–phosphorus ratio enhanced chondrocyte proliferation, glycosaminoglycan production, and induced an early onset of alkaline phosphorus activity, while the ceramic with lower calcium–phosphorus ratio performed similarly to the ceramic‐free control. These results underscore the importance of ceramic bioactivity in directing chondrocyte response, and demonstrate that Ca/P ratio is a key parameter to be considered in osteochondral scaffold design. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2694–2702, 2017.